J. Allyson Hays, M.D.

J. Allyson Hays, MD

Maiden name: Julia Allyson Niece

Assistant Professor, Pediatrics

Division of Hematology/Oncology

2401 Gillham Rd

Kansas City, MO64108

(816) 234-3265 (work) (816) 855-1700 (fax)

EDUCATION

08/1996 - 12/2001 B.A. in Liberal Arts

University of Missouri-Kansas City, Kansas City, MO

08/1996 - 05/2002 Doctor of Medicine

University of Missouri- Kansas City, Kansas City, MO

7/2006 – 6/2008 Graduate Certificate in Clinical Sciences

University of Texas Southwestern GraduateSchool of

Biomedical Sciences, Dallas, TX

POST-GRADUATE TRAINING

07/2002 - 06/2005Pediatric Internship and Residency

Tulane University/Ochsner Hospital for Children, New Orleans, LA

07/2005 - 06/2008 Pediatric Hematology-Oncology Fellow

UT Southwestern MedicalCenter at Dallas

07/2007 - 06/2008Chief Fellow, Pediatric Hematology/Oncology

UT Southwestern MedicalCenter at Dallas

CERTIFICATION/LICENSURE

10/06-10/13American Board of Pediatrics Certification, General Pediatrics

5/08-12/13Missouri Medical license #2008012511

3/09-3/16American Board of Pediatrics Certification, Pediatric Hematology-Oncology #2200

6/08-6/14Kansas Medical license #04-33145

5/7/08-8/31/08Kansas Temporary Permit T-01868, inactive

Exp 8/08Texas Training Permit BP10023096, inactive

Exp 8/08Texas Medical License M2816, inactive

Exp 6/05Louisiana Medical License MD026039, inactive

ACADEMIC APPOINTMENTS

Assistant Professor, Pediatrics, University of Missouri- Kansas City School of Medicine, 7/08-present

APPOINTMENTS AT HOSPITALS/AFFILIATED INSTITUTIONS

Pediatric Hematology/Oncology Attending, Children’s Mercy Hospital, 7/08-present

PROFESSIONAL AFFILIATIONS

07/2002- 07/2009American Academy of Pediatrics

07/2005- present American Society of Clinical Oncology

07/2005- presentAmerican Society of Hematology

07/2005- presentAmerican Society of Pediatric Hematology/Oncology

09/2007- 09/2008American Medical Association

11/2007- presentHistiocyte Society

MANUSCRIPT

Niece JA, Rogers ZR, Ahmad N, Langevin AM, McClain KL. “Hemophagocytic Lymphohistiocytosis in Texas: Observations on Ethnicity and Race.” Pediatric Blood Cancer 2010; 54:424-28.

ChanghoSC, Niece JA, Saunders C, RivardDC, Ahmed A. “Pediatric Gastrointestinal Stromal Tumors in Assocation with Neuroblastoma.” APMIS 2011; 119 (2) 164-6.

ABSTRACTS

Niece JA, Ahmad N, Rogers ZR. “Contemporary Patients with Hemophagocytic Lymphohistiocytosis: An Institutional Experience.” Journal of Clinical Oncology. 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 20022.

Niece JA, Ahmad N, Rogers ZR, McClain KL. “Evolution of Hemophagocytic Lymphohistiocytosis: A Texas Experience. Poster Presentation American Society of Pediatric Hematology/Oncology 21st Annual Meeting 2008. Online abstracts only: www3.interscience.wiley.com/homepages / 106561790/ASPHO_Abstracts_-_2008.pdf

POSTER PRESENTATIONS

Hays JA, Fisher C, O’Neill K, Monsees EA, Lightner TS, Diggs AM, Held K, Long SA, Marsh J, Thomas J, Thompson ML, Larte L. “Central Line Assoicated Blood Stream Infection Prevention in the Hem/Onc Patient”. 2011 National Healthcare Quality Week, Children’s Mercy Hospital, Kansas City, Missouri.

Hays JA, Watt M, Antes A, Hunter M, Smith T. “Implementation of Central Line Rounds in Children with Hematologic/Oncologic Disorders”. 2013 National Healthcare Quality Week, Children’s Mercy Hospital, Kansas City, Missouri.

FORMAL PRESENTATIONS

  1. The Past, Present, and Future of Hemophagocytic Lymphohistiocytosis, Pediatric Hematology Oncology Grand Rounds, University of Texas Southwestern Medical Center at Dallas, May 2007.
  1. Hemophagocytic Lymphohistiocytosis, Pediatric Fellows Research Conference, University of Texas Southwestern Medical Center at Dallas, May 2007.
  1. The Past, Present, and Future of Hemophagocytic Lymphohistiocytosis,Division of Pediatric Hematology/Oncology Visiting Faculty Applicant, Children’s Mercy Hospital, Kansas City, Missouri, January 2008.
  1. The Alphabet Soup of Histiocytosis, Pediatric Grand Rounds, Children’s Mercy Hospital, January 2009.
  1. Histiocytosis in Children & Adults, Department of Family Medicine, Truman Medical Center Lakewood, August 2009.
  1. Hemophagocytic Lymphohistiocytosis. Medical Oncology Fellows and staff, Truman Medical Center, July 2013.

RESEARCH ACTIVITIES

  1. Principal Investigator, Central Line Associated Bloodstream Infections in Pediatric Hematology/Oncology Patients, Children’s Hospital Association (formerly NACHRI). 2009-present.
  2. Principal Investigator, Hemophagocytic Lymphohistiocytosis (HLH): A Mimicker of Sepsis in the Pediatric Intensive Care Unit, 2012-present.

HOSPITAL COMMITTEES:

-Central Line Strategic Initiative for Bloodstream infection

-Principle Investigator for the Children’s Healthcare Association collaborative on Central Line infection in Pediatric Hematology/Oncology Patients, 11/09-present.

-Clinical Competency Committee for Pediatric Hematology/Oncology Fellows

MENTORING:

  • Spring Docent, PGY1 medical students, UMKC, 2013, 2014
  • Career Fair liaison for PHO, PGY1, 2 UMKC 2010, 2013
  • “Breaking Bad News” module for fellows, Spring 2013
  • End of Life Palliative Care teaching from ASPHO, Spring 2013
  • NICU fellow presentation on HLH, 11/20/13
  • Pediatric Resident, Professor Rounds, 3/25/13

RESEARCH SUPPORT AND TRAINING

5 K30 RR022269 08/2006-06/2008

Title: Training Curriculum in Patient-Oriented Research

PI: Robert Toto, MD

Role: Clinical Research Student Clinical Research Student

Source: National Institutes of Health

Goal: To provide education in clinical research to medical personnel

Hematology-Oncology Fellowship Award 07/2007-06/2008

Title: Early Recognition of Hemophagocytic Lymphohistiocytosis

PI: Allyson Niece, MD

Role: Principal Investigator

Source: Amgen Oncology Institute

Goal: To support further studies of Hemophagocytic Lymphohistiocytosis

Investigator Initiated Trial7/2011-present

Title: Hemophagocytic Lymphohistiocytosis: A Mimicker of Sepsis in the Pediatric Intensive Care Unit

PI: Allyson Hays, MD

Role: Principle Investigator

Source: Children’s Mercy Cancer Center Auxiliary Board $24,307

Goal: To evaluate children with sepsis in the PICU for laboratory evidence of HLH and to establish ranges for novel cytokines associated with macrophage activation.

COMMUNITY INVOLVEMENT:

Medical Mission 2004, 2006-2010Volunteer Participant Jinotega, Nicaragua

Outreach clinics providing physical examinations and anticipatory guidance